Nephros, Inc. (NASDAQ:NEPH) Sees Large Drop in Short Interest

Nephros, Inc. (NASDAQ:NEPH) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 11,400 shares, a decrease of 45.7% from the March 31st total of 21,000 shares. Based on an average daily trading volume, of 14,000 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.1% of the shares of the stock are short sold.

Institutional Investors Weigh In On Nephros

An institutional investor recently bought a new position in Nephros stock. Topline Capital Management LLC bought a new position in shares of Nephros, Inc. (NASDAQ:NEPH) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned 3.98% of Nephros as of its most recent SEC filing. 41.10% of the stock is currently owned by hedge funds and other institutional investors.

Nephros Stock Down 3.0 %

Shares of Nephros stock opened at $1.95 on Tuesday. The firm has a market cap of $20.67 million, a price-to-earnings ratio of -21.67 and a beta of 1.05. The business has a fifty day simple moving average of $1.73 and a 200-day simple moving average of $1.60. Nephros has a fifty-two week low of $1.36 and a fifty-two week high of $2.55.

Nephros (NASDAQ:NEPH) last announced its earnings results on Monday, March 24th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.04. The company had revenue of $3.87 million for the quarter, compared to analyst estimates of $3.67 million. Nephros had a negative return on equity of 11.39% and a negative net margin of 6.86%.

Nephros Company Profile

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.